DVA

DaVita Inc.

$179.28

-3.37%
SectorHealthcareIndustryMedical Care FacilitiesCountryUnited States

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc.

Source: Yahoo Finance
AI summary

Price & performance

1M+7.2%
3M-21.5%
YTD+63.7%
1Y+57.9%
52-week range—
Beta0.39
Full chart and returns against a benchmark

Q-Score

78/ 100

Quality against peers; 50 is the peer median.

Growth63
Risk70
Performance64
Valuation75
Profitability73
Leverage66
Sentiment43
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$13.6B+6.5%
Net income$746.8M-20.2%
Net margin5.5%-1.8 pts
Historical fundamentals

Revenue exposure

Regions, segments, customers and suppliers

Valuation

DVAIndustryP/E12.2612.66P/S0.801.15EV/EBITDA7.6313.41P/B—7.42PEG0.640.49
Dividend yield0.10%
Every valuation metric

Earnings

Oct 29next report, after the close
EPS estimate$3.57
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate